Related Experiment Video
Updated: Dec 2, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
My Diabetes Coach, a Mobile App-Based Interactive Conversational Agent to Support Type 2 Diabetes Self-Management:
Enying Gong1, Shaira Baptista1,2, Anthony Russell3,4
1School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
The My Diabetes Coach app improved quality of life for type 2 diabetes patients but did not significantly lower HbA1c levels. This digital health tool shows promise for supporting diabetes self-management.
Area of Science:
- Digital health interventions
- Behavioral science
- Chronic disease management
Background:
- Self-management support is crucial for type 2 diabetes mellitus (T2DM) to reduce health system burden.
- Empowering individuals with skills and confidence is key for active health management.
Purpose of the Study:
- Evaluate the adoption, use, and effectiveness of the My Diabetes Coach (MDC) program.
- Assess an app-based conversational agent (Laura) for diabetes self-management over 12 months.
Main Methods:
- Randomized controlled trial (RCT) in Australia with adults with T2DM.
- Intervention group received MDC; control group received usual care.
- Coprimary outcomes: glycated hemoglobin (HbA1c) and health-related quality of life (HRQoL) measured at baseline, 6, and 12 months.
Main Results:
- 187 adults with T2DM were randomized. MDC users engaged in an average of 243 minutes of interaction over 12 months.
- No statistically significant difference in HbA1c reduction between MDC and control groups (net difference: -0.04%, P=.83).
- HRQoL utility scores significantly improved in the MDC group compared to the control group (difference: 0.04, P=.04).
Conclusions:
- The MDC program was successfully adopted and utilized by individuals with T2DM.
- The program significantly improved users' health-related quality of life.
- Technology-enabled conversational programs hold potential for diabetes self-management support, though further research is needed to enhance HbA1c outcomes.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

